Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yevgeniy Gindin

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Hepatology (Baltimore, Md.)|August 4, 2020
A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing CholangitisYevgeniy Gindin, Chuhan Chung, Zhaoshi Jiang, et al.
Cancer Research|July 17, 2013
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacologyOgan D Abaan, Eric C Polley, Sean R Davis, et al.
Cell|October 14, 2022
En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASHMasaki Kimura, Takuma Iguchi, Kentaro Iwasawa, et al.
Nature Communications|August 10, 2016
Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancersChristopher A Miller, Yevgeniy Gindin, Charles Lu, et al.
Plos Genetics|August 23, 2012
Mutational signatures of de-differentiation in functional non-coding regions of melanoma genomesStephen C J Parker, Jared Gartner, Isabel Cardenas-Navia, et al.
Cancer Discovery|April 9, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven CancersJingjing Jiang, Lingyan Jiang, Benjamin J Maldonato, et al.
Nature|April 8, 2024
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMatthew Holderfield, Bianca J Lee, Jingjing Jiang, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinomaUrszula N Wasko, Jingjing Jiang, Alvaro Curiel-Garcia, et al.
Nature|April 8, 2024
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancerUrszula N Wasko, Jingjing Jiang, Tanner C Dalton, et al.
Nature Genetics|June 2, 2022
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validationMarijana Vujkovic, Shweta Ramdas, Kim M Lorenz, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Hepatology (Baltimore, Md.)|August 4, 2020
A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing CholangitisYevgeniy Gindin, Chuhan Chung, Zhaoshi Jiang, et al.
Cancer Research|July 17, 2013
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacologyOgan D Abaan, Eric C Polley, Sean R Davis, et al.
Cell|October 14, 2022
En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASHMasaki Kimura, Takuma Iguchi, Kentaro Iwasawa, et al.
Nature Communications|August 10, 2016
Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancersChristopher A Miller, Yevgeniy Gindin, Charles Lu, et al.
Plos Genetics|August 23, 2012
Mutational signatures of de-differentiation in functional non-coding regions of melanoma genomesStephen C J Parker, Jared Gartner, Isabel Cardenas-Navia, et al.
Cancer Discovery|April 9, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven CancersJingjing Jiang, Lingyan Jiang, Benjamin J Maldonato, et al.
Nature|April 8, 2024
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMatthew Holderfield, Bianca J Lee, Jingjing Jiang, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinomaUrszula N Wasko, Jingjing Jiang, Alvaro Curiel-Garcia, et al.
Nature|April 8, 2024
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancerUrszula N Wasko, Jingjing Jiang, Tanner C Dalton, et al.
Nature Genetics|June 2, 2022
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validationMarijana Vujkovic, Shweta Ramdas, Kim M Lorenz, et al.
Pageof 2